Pulmonary infection with an interferon-γ-producing cryptococcus neoformans strain results in classical macrophage activation and protection

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 774-785

  Hardison, Sarah E ^a   Ravi, Sailatha ^a   Wozniak, Karen L ^a   Young, Mattie L ^a   Olszewski, Michal A ^b,c   Wormley Jr , Floyd L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE MANNOSE RECEPTOR; MANNOSE RECEPTOR; UNCLASSIFIED DRUG; YM 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROTECTION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; ENCAPSULATION; FEMALE; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; GENE EXPRESSION; HISTOLOGY; LEUKOCYTE; LUNG INFECTION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TRANSGENE; WILD TYPE;

EID: 76149115571     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090634     Document Type: Article

References (49)

1. Mitchell TG, Perfect JR: Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995, 8:515-548
2. Powderly WG: Cryptococcal meningitis and AIDS. Clin Infect Dis 1993, 17:837-842
3. Aguirre K, Havell EA, Gibson GW, Johnson LL: Role of tumor necrosis factor and γ interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995, 63:1725-1731
4. Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB: Role of IFN-γ in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol 2005, 174:6346-6356
5. Collins HL, Bancroft GJ: Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 1992, 22:1447-1454
6. Flesch IE, Schwamberger G, Kaufmann SH: Fungicidal activity of IFN-γ-activated macrophages. Extracellular killing of Cryptococcus neoformans. J Immunol 1989, 142:3219-3224
7. Huffnagle GB, Lipscomb MF: Cells and cytokines in pulmonary cryptococcosis. Res Immunol 1998, 149:387-396; discussion 512-514
8. Levitz SM, DiBenedetto DJ: Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect Immun 1988, 56:2544-2551
9. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE: IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 2002, 3:7
10. Mody CH, Tyler CL, Sitrin RG, Jackson C, Toews GB: Interferon-γ activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol 1991, 5:19-26
11. Müller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, Schutze N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber G: IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 2007, 179:5367-5377
12. Osterholzer JJ, Surana R, Milam JE, Montano GT, Chen GH, Sonstein J, Curtis JL, Huffnagle GB, Toews GB, Olszewski MA: Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am J Pathol 2009, 174:932-943
13. Chen GH, Olszewski MA, McDonald RA, Wells JC, Paine R 3rd, Huffnagle GB, Toews GB: Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol 2007, 170:1028-1040
14. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Chensue SW, Kunkel SL: TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. Eur J Immunol 2007, 37:2847-2855
15. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483
16. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA: Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 2001, 167:6533-6544
17. Chang NC, Hung SI, Hwa KY, Kato I, Chen JE, Liu CH, Chang AC: A macrophage protein. Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem 2001, 276:17497-17506
18. Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P, Hakiy N, Klemke CD, Dippel E, Kodelja V, Orfanos CE: Alternative versus classical activation of macrophages. Pathobiology 1999, 67:222-226
19. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35
20. Stein M, Keshav S, Harris N, Gordon S: Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992, 176:287-292
21. De Groot PW, Ram AF, Klis FM: Features and functions of covalently linked proteins in fungal cell walls. Fungal Genet Biol 2005, 42:657-675
22. Noverr MC, Cox GM, Perfect JR, Huffnagle GB: Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 2003, 71:1538-1547
23. Wormley FL Jr, Perfect JR, Steele C, Cox GM: Protection against cryptococcosis by using a murine γ interferon-producing Cryptococcus neoformans strain. Infect Immun 2007, 75:1453-1462
24. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, Perfect JR: Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001, 39:166-175
25. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR: Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000, 68:443-448
26. Aarskog NK, Vedeler CA: Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 2000, 107:494-498
27. Chang JT, Chen IH, Liao CT, Wang HM, Hsu YM, Hung KF, Lin CJ, Hsieh LL, Cheng AJ: A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients. Clin Biochem 2002, 35:591-596
28. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3:RESEARCH0034
29. Young M, Macias S, Thomas D, Wormley FL Jr: A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics 2009, 9:2578-2588
30. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL: Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One 2009, 4:e6854
31. Büttner C, Skupin A, Reimann T, Rieber EP, Unteregger G, Geyer P, Frank KH: Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol 1997, 17: 315-325
32. Hancock A, Armstrong L, Gama R, Millar A: Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 1998, 18:60-65
33. Hauber HP, Gholami D, Meyer A, Pforte A: Increased interleukin-13 expression in patients with sarcoidosis. Thorax 2003, 58:519-524
34. Pouliot P, Turmel V, Gelinas E, Laviolette M, Bissonnette EY: Interleukin-4 production by human alveolar macrophages. Clin Exp Allergy 2005, 35:804-810
35. Prieto J, Lensmar C, Roquet A, van der Ploeg I, Gigliotti D, Eklund A, Grunewald J: Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 2000, 94: 806-814
36. Shirey KA, Cole LE, Keegan AD, Vogel SN: Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol 2008, 181:4159-4167
37. Szymczak WA, Deepe GS Jr: The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol 2009, 183:1964-1974
38. Guo L, Johnson RS, Schuh JC: Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice. J Biol Chem 2000, 275:8032-8037
39. Loke P, MacDonald AS, Robb A, Maizels RM, Allen JE: Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol 2000, 30:2669-2678
40. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, Hassanzadeh Gh G: Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 2002, 71:597-602
41. Welch JS, Escoubet-Lozach L, Sykes DB, Liddiard K, Greaves DR, Glass CK: TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem 2002, 277:42821-42829
42. Allen JE, Loke P: Divergent roles for macrophages in lymphatic filariasis. Parasite Immunol 2001, 23:345-352
43. Forman HJ, Torres M: Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 2002, 166:S4-S8
44. Hickman-Davis JM, Fang FC, Nathan C, Shepherd VL, Voelker DR, Wright JR: Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions. Am J Physiol Lung Cell Mol Physiol 2001, 281:L517-L523
45. Hickman-Davis JM, O'Reilly P, Davis IC, Peti-Peterdi J, Davis G, Young KR, Devlin RB, Matalon S: Killing of Klebsiella pneumoniae by human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002, 282:L944-L956
46. Voelz K, Lammas DA, May RC: Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun 2009, 77:3450-3457
47. Noël W, Raes G, Hassanzadeh Ghassabeh G, De Baetselier P, Beschin A: Alternatively activated macrophages during parasite infections. Trends Parasitol 2004, 20:126-133
48. Schindler H, Lutz MB, Rollinghoff M, Bogdan C: The production of IFN-γ by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol 2001, 166:3075-3082
49. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787